3rd Annual Cell & Gene Therapy Congress

 

25 - 26 October, London

Over 250 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions. Over 20 presentations and case studies focused on the key issues in cell & gene therapy development, updates in regulatory pathways, commercialisation, bioprocessing and manufacturing.